ADAKVEO FDA approval date

The FDA approved ADAKVEO on 15 Nov 2019.

FDA approval date
15 Nov 2019

Drug identity has not yet been verified against registry records

Also recorded as CRIZANLIZUMAB-TMCA

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2019-11-15DayADAKVEOFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA761128", "applicant_as_listed_by_fda": "NOVARTIS PHARMS CORP", "brand_names": ["ADAKVEO"], "active_ingredients": ["CRIZANLIZUMAB-TMCA"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20191115", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026